Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CVRX


Fundamental

Company: CVRx Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.02
Insider Own: 39.82%
Shs Outstand: 26.19M
Perf Week: -9.27%
Market Cap: 214.27M
Forward P/E: -
EPS next Y: -1.91
Insider Trans: -0.59%
Shs Float: 15.77M
Perf Month: -8.25%
Enterprise Value: 179.67M
PEG: -
EPS next Q: -0.44
Inst Own: 30.50%
Short Float: 9.45%
Perf Quarter: 17.63%
Income: -52.02M
P/S: 3.83
EPS this Y: 23.23%
Inst Trans: -2.34%
Short Ratio: 6.90
Perf Half Y: 39.03%
Sales: 55.97M
P/B: 4.46
EPS next Y Percentage: 6.29%
ROA: -43.53%
Short Interest: 1.49M
Perf YTD: -35.48%
Book/sh: 1.83
P/C: 2.52
EPS next 5Y: 15.37%
ROE: -91.88%
52W High: 18.55 -55.93%
Perf Year: -39.93%
Cash/sh: 3.25
P/FCF: -
EPS past 3/5Y: -7.91% -28.44%
ROIC: -52.96%
52W Low: 4.30 90.15%
Perf 3Y: -41.36%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 57.87% 52.31%
Gross Margin: 83.15%
Volatility W: 8.64%
Volatility M: 7.71%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 3.21
EPS Y/Y TTM: 25.42%
Oper. Margin: -89.97%
ATR (14): 0.66
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.60
Sales Y/Y TTM: 18.44%
Profit Margin: -92.95%
RSI (14): 33.97
Recom: 1.57
Dividend Gr. 3/5Y: - -
Current Ratio: 9.62
EPS Q/Q: 14.45%
SMA20: -10.53%
Beta: 1.27
Target Price: 11.50
Payout: -
Debt/Eq: 1.05
Sales Q/Q: 9.85%
SMA50: -14.01%
Rel Volume: 0.64
Prev Close: 8.45
Employees: 206
LT Debt/Eq: 1.04
Earnings: Nov 05 AMC
SMA200: -1.60%
Avg Volume: 215.84K
Price: 8.18
IPO: Jun 30, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 0.59% 1.99%
Trades:
Volume: 138,013
Change: -3.25%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z
William Blair cuts CVRx stock rating on salesforce issues - Investing.com somewhat bearish
CVRX

Summary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.

Full article
2024-05-01T17:35:02Z